retatrutide clinical trial obesity New GLP-1 drug, retatrutide, shows added benefits retatrutide benefits clinical trial The

Ozempic weight loss results Semaglutide (available as Ozempic or Wegovy) leads to significantly greater weight loss: Patients lose an average of 15% of their body weight (over a 68-week trial) Some lose as much as 20% of their body weight About 86% of people taking semaglutide lose at least 5% of their weight, and 50% lose 15% or more For someone starting at 200 pounds, that's about 30-40 pounds lost with semaglutide compared to 10-20 pounds with phentermine

Semaglutide works by helping you feel full sooner and ultimately reduces the desire to eat more

Several innovative strategies should be prioritized to overcome these obstacles

( 8 ) Studies have shown that some patients taking tirzepatide achieved a weight loss of nearly 27% over an 84-week period